viernes, 20 de enero de 2017

Cancer Information Highlights, January 18, 2017

Cancer Information Highlights, January 18, 2017

National Cancer Institute

New from NCI
Facebook Live Event about Cervical Cancer Treatment
January Facebook Live Event Thursday, January 26, 2017 at 2:00 p.m.

NCI's Dr. Christina Annunziata and Dr. Sarah Temkin from Virginia Commonwealth University will discuss cervical cancer treatment and clinical trials.  
For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain
clinician’s hand holding patient’s hand Results of a randomized clinical trial show that a drug most commonly used to treat depression may also reduce joint pain caused by drugs used to prevent breast cancer from returning.
Relief for Chronic Graft-Versus-Host Disease Symptoms

A small clinical trial shows that ibrutinib can treat symptoms of chronic graft-versus-host disease. Ibrutinib is a targeted cancer therapy.
Mammogram Fact Sheet

We’ve updated this fact sheet to include the latest information about factors related to false-positive test results, categories of breast density that require reporting, and two new research studies.
Drug Information Updates
New Drug for Ovarian Cancer

We've added a new drug summary for rucaparib camsylate. It was recently approved by the Food and Drug Administration (FDA) to treat advanced ovarian cancer with BRCA1 or BRCA2 gene mutations in patients who have already been treated with chemotherapy.
 
Also of Interest
Hair Dyes and Cancer Risk

This fact sheet reviews the research on a possible link between personal hair dye use and cancer.
Drugs Approved for Cervical Cancer

This page lists cancer drugs that the FDA has approved to treat cervical cancer.
Find NCI-Supported Clinical Trials

Find an NCI-supported clinical trial and learn how to locate other research studies that may be right for you or a loved one.
Cancer Information Highlights, January 18, 2017

NEW Funding Opportunity from the HHS Office on Women’s Health

NEW Funding Opportunity from the HHS Office on Women’s Health

Main Header

The HHS Office on Women’s Health invites you to apply for the Prevention of Opioid Misuse in Women: Office on Women’s Health Prevention Awards. You can apply here.
Up to 12 projects (cooperative agreements) will be funded to prevent the misuse of opioids by women across their lifespans. Projects must focus on primary or secondary prevention efforts only and include partnership and collaboration components. Regional, state, local, and community organizations should propose organized activities to achieve this goal through:
  • program development and implementation,
  • health education targeting health professionals and/or women directly, or
  • policy efforts to support primary and/or secondary prevention.
All projects will include an evaluation component. All projects will seek to include socioeconomic diversity and consider cultural and social determinants that may function as barriers to prevention and treatment, such as the fear of criminalization of substance abuse, negative stigma associated with substance abuse, and the implicit and systemic bias of health professionals and health.
Follow OWH on Twitter for updates!

Fogarty/NIH news: Focus on big data, Paul Farmer, trauma and injury grants

eNews Header: Global Health Matters e-News from Fogarty International Center
Print-friendly PDF

January / February 2017

Humanitarian Paul Farmer discusses global health equity

Dr. Paul Farmer, co-founder of Partners in Health, addressed global health equity as he presented the Barmes Global Health Lecture at NIH in December 2016.
>> Full article
Paul Farmer speaking at a podium at NIH, slide projected in the background

Bright orange flames surrounded by dark black smoke in a city street, buildings in background, people in foreground

Fogarty invests $10M in trauma, injury training

​Fogarty is funding projects to train investigators in low- and middle-income countries to research the most effective ways to prevent and treat injuries.
>> Full article

Looking forward to 2017 with optimism

​Fogarty Director Dr. Roger I. Glass is feeling energized to begin the new year, with so many opportunities to advance global health on the horizon.
>> Full article
Roger Glass poses outdoors with a group of African children

Dr. Soumya Swaminathan

Q and A with former Fogarty trainee
Dr Soumya Swaminathan

Former Fogarty trainee Dr. Soumya Swaminathan, now Director General of the Indian Council of Medical Research, discusses the impact of Fogarty on her career, and the future of U.S.-India research collaborations.
>> Full article

Profile: Fogarty Fellow Dr Emmanuel Balandya studies sickle cell immunity

Dr. Emmanuel Balandya hopes data from his research in Tanzania as a Fogarty Global Health Fellow on immune cells in sickle cell disease will bring more interventions to Africa.
>> Full article
Dr. Emmanuel Balandya points to an item on a scientific poster in a conference room

Woman uses smartphone, large group of women in the background also using smartphones

Focus: Big data for infectious disease surveillance, modeling

A team of scientists led by the NIH reviewed the growing body of research on big data and has published its analyses in a special issue of The Journal of Infectious Diseases.
>> Full article

Also in this issue

E-news extras

Stay connected with Fogarty

Funding opportunities: Upcoming deadlines

Upcoming events